Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4LD9G
|
|||
| Drug Name |
PF-07307405
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Lyme disease [ICD-11: 1C1G; ICD-10: A69.2; ICD-9: 88.81] | Phase 3 | [1] | |
| Company |
Pfzer
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05634811) A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY OF A 6-VALENT OspA-BASED LYME DISEASE VACCINE (VLA15) IN HEALTHY CHILDREN 5 THROUGH 17 YEARS OF AGE. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.